Connect your AI

Syndax Pharmaceuticals SNDX Price / book

Price / book at other companies

BiogenBIIB

1.4×+0.3×

IncyteINCY

3.3×+0.1×

SELLAS Life Sciences Group, Inc.SLS

7.1×+3.5×

AbbVieABBV

261×+221×

ArriVent BioPharma, Inc.AVBP

3.1×0.0×

Viridian Therapeutics, Inc.VRDN

3.1×+1.3×

Other financials

Income statement

Revenue$64.9M+224%

Operating income-$34.2M+59.2%

Net income-$42.7M+49.7%

EPS (diluted)-$0.48+51.0%

Balance sheet

Cash & equivalents$130.9M-15.0%

Total debt$350.5M+4.2%

Total equity$41.6M-80.6%

Total assets$472.7M-26.2%

Cash flow

Operating cash flow-$50.3M+47.1%

CapEx$46.8K—

Free cash flow-$80.8M-17.6%

Valuation

Market cap$1.74B+95.0%

Enterprise value$1.96B+84.0%

P/S8×-12.4×

Profitability

Operating margin-102.8%-47.8pp

Net margin-111.9%-51.5pp

FCF margin-187.2%-85.4pp

Returns & leverage

Return on equity-189.5%-8,509pp

Debt / equity8.4×+6.9×

Current ratio5.5×-0.3×

Where this comes from

Calculated from Syndax Pharmaceuticals’s reported figures.

market cap/total stockholders equity=49.5×

Based on the most recent quarter.

The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Syndax Pharmaceuticals's price / book?: Syndax Pharmaceuticals (SNDX) reported price / book of 49.5× in Q1 2026.
How has Syndax Pharmaceuticals's price / book changed year-over-year?: Syndax Pharmaceuticals's price / book increased by 907.4% year-over-year, from 4.9× to 49.5×.
What is the long-term trend for Syndax Pharmaceuticals's price / book?: Over 5 years (2020 to 2025), Syndax Pharmaceuticals's price / book has grown at a 42.8% compound annual growth rate (CAGR), from 4.8× to 28.3×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.